# Phase30-F — 2023-10-27 Current Valuation Refresh HALT Recurrence Audit

## Task ID

`Phase30-F`

## Target Run

`runtime-test-historical-extended-smoke-20260815T061857447380Z`

## Scope

Read-only recurrence and contamination-boundary audit for the HALT at:

```text
2023-10-27:current_valuation_refresh
```

No run resume, fresh-run, replay, close, repair, configuration change, strategy
change, threshold change, or target-run artifact mutation was authorized or
performed.

---

## Primary Judgment

```text
PHASE30_F_20231027_CURRENT_VALUATION_HALT_SAME_ROOT_CAUSE_REPRODUCED_PREHALT_EVIDENCE_VALID_RESEARCH_PIVOT_READY_RUNTIME_CONTINUITY_NOT_READY
```

The current long Historical run reached the same 2023-10-27
`current_valuation_refresh` gate as the previous run and halted fail-closed
because a held-position quote for `76710` was unavailable for the target
valuation date.

This is not a recurrence of the Phase29 valuation/basis defect. The completed
segment remains clean through `2023-10-26`, and the available 299 completed
business days are sufficient to support Phase30 stock-selection, continuation,
and hold/sell research while runtime continuity repair is tracked separately.

---

## Exact HALT Cause

Authoritative daily evidence:

```text
reports/runtime_tests/runs/runtime-test-historical-extended-smoke-20260815T061857447380Z/daily/2023-10-27/current_valuation_refresh/
```

Observed state:

```text
run_state.status        = HALT
run_state.next_job      = 2023-10-27:current_valuation_refresh
completed_count         = 299
last_completed          = 2023-10-26
daily cli exit_code     = 20
```

The daily `cli_result.json` is the authoritative job-level exit evidence. The
top-level `run_state.json` records the HALT and next job, while the daily CLI
artifact records the `current_valuation_refresh` exit code.

Failure chain:

```text
persistent Current + 2023-10-27 market evidence
-> current_valuation_refresh projection
-> missing held-position quote for 76710
-> current_valuation_review_required
-> valuation_apply_evidence.status NOT_APPLIED
-> postcondition NOT_EXECUTED
-> CLI exit_code 20
-> runtime HALT at 2023-10-27:current_valuation_refresh
```

Canonical failure class:

```text
HELD_POSITION_QUOTE_MISSING_FAIL_CLOSED_CURRENT_VALUATION_REVIEW_REQUIRED
```

Authority details:

| Evidence | Result |
|---|---|
| `current_valuation_manifest.json` | `status = REVIEW_REQUIRED` |
| `current_valuation_manifest.json` | `reason = current_valuation_review_required` |
| `current_valuation_manifest.json` | `missing_symbols = ["76710"]` |
| `current_valuation_manifest.json` | `missing_evidence = ["76710", "current_valuation_quote_missing", "quote_status_not_allowed"]` |
| `valuation_projection.json` | `projection_status = REVIEW_REQUIRED` |
| `valuation_projection.json` | `valuation_refresh_precondition_status = PASS` |
| `valuation_projection.json` | `valuation_refresh_action = APPLY` |
| `valuation_apply_evidence.json` | `status = NOT_APPLIED` |
| `current_valuation_manifest.json` | `postcondition_status = NOT_EXECUTED` |
| `current_valuation_manifest.json` | `postcondition_reason = apply_not_executed_because_projection_not_ready` |
| `market_evidence_authority.json` | `status = PASS`, `missing_symbols = ["76710"]` |
| `safety_authority_decision.json` | `status = PASS`, `safety_decision = NEUTRAL` |
| `external_effect_audit.json` | `status = PASS`, no broker write or prohibited external effect |

This was not caused by Strategy decision logic, Safety rejection, malformed
evidence, corporate-action ambiguity, quantity/basis mismatch, or valuation
application after a failed projection. The valuation candidate was blocked
before apply.

---

## 76710 Symbol-Level Evidence

Position evidence at the halted valuation candidate:

| Field | Value |
|---|---:|
| Symbol | `76710` |
| Quantity | `100` |
| Average price | `948.0` |
| Cost basis | `94,800` |
| Candidate valuation price | `949.0` |
| Candidate market value | `94,900` |
| Candidate unrealized PnL | `100` |
| Quantity basis | `ADJUSTED` |
| Valuation price basis | `ADJUSTED` |
| Quantity provenance | `runtime_execution_price_authority:adjusted_reference_price_basis` |
| Valuation price role | `reconciled_adjusted_basis_valuation_price` |

Market evidence around the HALT:

| Date | Evidence |
|---|---|
| `2023-10-25` | normalized/raw row exists for `76710`; adjusted and raw/economic close both `949`, ratio `1.0` |
| `2023-10-26` | normalized/raw row exists for `76710`; adjusted and raw/economic close both `949`, ratio `1.0` |
| `2023-10-27` | no raw or normalized bar row found for `76710`; no quote key available for valuation |

Execution evidence:

| Date | Evidence |
|---|---|
| `2023-08-17` | only observed `76710` BUY: quantity `100`, execution price `948`, cash effect `-94,800` |
| `2023-10-27` | no `76710` execution; only relevant execution was a SELL of `61920` |

The `76710` basis metadata remained internally consistent. The HALT was caused
by missing current-day valuation evidence, not by an adjusted/raw basis
alternation.

---

## Previous 2023-10-27 Comparison

Previous comparable run:

```text
runtime-test-historical-extended-smoke-20260814T131647480030Z
```

Comparison:

| Item | Previous run | Current run |
|---|---|---|
| Stop date | `2023-10-27` | `2023-10-27` |
| Stop job | `current_valuation_refresh` | `current_valuation_refresh` |
| Completed count | `299` | `299` |
| Last completed day | `2023-10-26` | `2023-10-26` |
| Job exit code | `20` | `20` |
| Manifest status | `REVIEW_REQUIRED` | `REVIEW_REQUIRED` |
| Missing symbol | `76710` | `76710` |
| Missing evidence | `current_valuation_quote_missing`, `quote_status_not_allowed` | `current_valuation_quote_missing`, `quote_status_not_allowed` |
| Apply status | `NOT_EXECUTED` / not applied | `NOT_EXECUTED` / not applied |

Canonical comparison result:

```text
SAME_ROOT_CAUSE_CONFIRMED
```

The current run did not progress beyond the previous 2023-10-27 gate. Runtime
long-horizon continuity is therefore still not validated past this date.

---

## Phase29 Valuation / Basis Recurrence

```text
PHASE29_VALUATION_BASIS_DEFECT_RECURRENCE = NO
```

Specific recurrence tests:

| Phase29 failure mode | Result |
|---|---|
| Adjusted analytical price used as economic valuation | `NO` |
| Raw price × adjusted-basis quantity | `NO` |
| Adjusted price × raw-basis quantity | `NO` |
| Basis metadata loss | `NO` through completed segment; `76710` candidate carries `ADJUSTED` / `ADJUSTED` |
| Day-to-day price alternation | `NO` |
| Contaminated Current valuation apply | `NO`; apply was blocked |

This is a different failure class from Phase29:

```text
HELD_POSITION_QUOTE_MISSING_FAIL_CLOSED_CURRENT_VALUATION_REVIEW_REQUIRED
```

---

## Earliest Contamination Boundary

```text
NO_PREHALT_CONTAMINATION_FOUND
```

Completed segment checks through `2023-10-26`:

| Check | Result |
|---|---:|
| Completed business days inspected | `299` |
| Current valuation manifest issues | `0` |
| Missing symbol valuation issues before HALT | `0` |
| Position-level quantity/valuation basis mismatches | `0` |
| Position valuation authority failures | `0` |

The earliest boundary requiring runtime attention is:

```text
2023-10-27 current_valuation_refresh pre-apply gate
```

No contaminated valuation was proven to enter capital authority, Portfolio
Construction, Position Sizing, Safety, or next-day decision evidence before the
HALT.

---

## Completed Segment Evidence Status

```text
VALID_THROUGH_2023_10_26
```

The completed 299-business-day segment remains valid for Phase30 performance,
stock-selection, continuation-quality, ADD quality, and HOLD/SELL research.
The 2023-10-27 current valuation apply did not execute, so performance beyond
`2023-10-26` is not part of the clean completed evidence boundary.

---

## Research Dataset Sufficiency

Research dataset status:

```text
SUFFICIENT_FOR_PHASE30_DEEP_RESEARCH
```

Counts from the completed segment:

| Dataset dimension | Count / coverage |
|---|---:|
| Completed business days | `299` |
| Window | `2022-08-10` through `2023-10-26` |
| BUY fills | `219` |
| SELL fills | `231` |
| Unique BUY symbols | `104` |
| BUY_NEW fills | `104` |
| BUY_ADD fills | `33` |
| REENTRY fills | `82` |
| EXIT sells | `179` |
| REDUCE sells | `52` |
| Position campaigns | `186` |
| Closed campaigns | `179` |
| Open campaigns at boundary | `7` |
| Campaigns with positive MFE | `105` |
| Meaningful MFE campaigns, >= 5,000 JPY | `30` |
| Immediate-adverse campaigns | `79` |
| Giveback candidates | `20` |
| Regime-labelled days | `299` |
| Regime transitions | `86` |

Regime coverage:

| Regime | Days |
|---|---:|
| `BULL` | `122` |
| `RECOVERY` | `52` |
| `RANGE` | `54` |
| `CORRECTION` | `21` |
| `BEAR` | `50` |
| `NORMAL` volatility regime | `299` |

The dataset is not a complete 977-business-day continuity proof, but it is
large and varied enough to proceed with Phase30 deep research on:

- objective stock selection quality,
- continuation quality / forward edge,
- entry timing,
- ADD versus BUY_NEW behavior,
- HOLD/SELL timing,
- MFE/giveback behavior,
- regime-specific degradation and resilience.

---

## Runtime Continuity Status

```text
RUNTIME_LONG_HORIZON_CONTINUITY_NOT_READY_SAME_2023_10_27_GATE_REPRODUCED
```

The same 2023-10-27 `current_valuation_refresh` stop was reproduced. The run
therefore cannot be used as evidence that Runtime can continue cleanly beyond
the earlier HALT point.

This does not invalidate the completed segment through `2023-10-26`.

---

## Resume Feasibility

Current Phase30-F authorization:

```text
NO RESUME AUTHORIZED
NO REPAIR AUTHORIZED
NO FRESH-RUN AUTHORIZED
```

Future resume classification:

```text
LIKELY_OPTION_A_CONDITIONAL_SAME_RUN_ID_RESUME_FROM_2023_10_27_CURRENT_VALUATION_REFRESH_AFTER_FIX_AND_IDEMPOTENCY_PROOF
```

Rationale:

- The failed `current_valuation_refresh` did not apply valuation.
- No pre-HALT valuation/basis contamination was found.
- The completed segment remains clean through `2023-10-26`.
- Current evidence does not prove that a fresh run is required.

Required invariants before any future resume:

- The resume must not re-execute or duplicate already-applied `2023-10-27`
  execution effects.
- The persistent Current pointer and hash must be proven to match the expected
  post-execution / pre-valuation boundary.
- The missing-quote policy for held-position valuation must be fixed or
  explicitly authorized.
- `valuation_apply_evidence` must remain not previously applied for
  `2023-10-27`.
- Pending, execution, cash, Current, and valuation-history idempotency must be
  proven before resume.

If a future runner cannot resume exactly at the halted
`2023-10-27:current_valuation_refresh` boundary without replaying prior
2023-10-27 jobs, state repair/reconstruction may be required. Phase30-F does
not authorize that work.

---

## Recommended Next Phase30 Task

Recommended path:

```text
FREEZE CURRENT LONG-RUN EVIDENCE
PIVOT TO DEEP STOCK-SELECTION / CONTINUATION / HOLD-SELL RESEARCH
TRACK HALT REPAIR AS SEPARATE RUNTIME WORKSTREAM
```

Recommended next research task:

```text
Phase30-G — Stock Selection Intelligence / PIT Data / Feature Authority Deep Audit
```

The 2023-10-27 HALT should be handled as a separate runtime continuity repair
workstream. It should not block Phase30 research that only consumes the clean
completed segment through `2023-10-26`.

---

## Implementation Authorization

```text
NO IMPLEMENTATION AUTHORIZED BY PHASE30_F
```

Actions performed:

- Read-only inspection of target run artifacts.
- Read-only comparison against the previous 2023-10-27 HALT run.
- Read-only inspection of completed-segment valuation, execution, campaign,
  and regime evidence.
- Documentation only.

Actions not performed:

- No target run mutation.
- No resume.
- No fresh-run.
- No replay.
- No close.
- No repair.
- No Strategy / Runtime / config / threshold change.
- No write into target run artifacts.

